| 指標 | 当期 | 前年同期 | YoY |
|---|---|---|---|
| Revenue / Net Sales | ¥32.1B | ¥26.0B | +23.6% |
| Operating Income / Operating Profit | ¥-1.0B | ¥2.4B | -38.3% |
| Ordinary Income | ¥-0.9B | ¥2.5B | -37.6% |
| Net Income / Net Profit | ¥-0.8B | ¥1.7B | -145.6% |
| ROE | -1.0% | 2.1% | - |
FY2027 Q1 results showed revenue of ¥32.1B (YoY +¥6.1B +23.6%), delivering top-line growth, but the company moved into a loss with Operating Income of ¥-1.0B (YoY -¥3.4B -142.5%), Ordinary Income of ¥-0.9B (YoY -¥3.4B -138.0%), and Net Income of ¥-0.8B (YoY -¥2.5B -145.6%). While revenue expanded steadily, SG&A rose to ¥24.3B (YoY +¥6.7B +38.4%), substantially outpacing revenue growth and causing the operating margin to deteriorate from 9.2% in the prior year to -3.2% (a 12.4pt decline). Gross margin also declined to 72.5% from 76.8% (a 4.3pt fall), turning the quarter from revenue-and-profit growth to revenue-up profit-down and representing a rapid deterioration in the profit structure.
[Revenue] Revenue of ¥32.1B (YoY +¥6.1B +23.6%) was driven by increased sales in a single segment (Health & Beauty Care related business). Cost of sales rose to ¥8.8B (YoY +¥2.8B +46.9%), increasing at a much faster pace than revenue growth, resulting in Gross Profit of ¥23.3B (YoY +¥3.3B +16.7%) and a Gross Margin of 72.5% (down 4.3pt from 76.8% a year ago). The decline in gross margin appears primarily due to changes in product mix and discounting pressure associated with inventory accumulation (YoY +28.5%).
[Profitability] SG&A amounted to ¥24.3B (YoY +¥6.7B +38.4%), rising well above the revenue growth rate of +23.6%. SG&A ratio increased to 75.7% (up 8.1pt from 67.6% a year ago), suggesting front-loaded spending on advertising and promotions. As a result, Operating Income was ¥-1.0B (prior year ¥+2.4B), and Operating Margin declined to -3.2% (down 12.4pt from +9.2% a year ago), resulting in an operating loss. Non-operating items were immaterial, with Non-operating Income of ¥0.1B (e.g., interest income ¥0.0B) and Non-operating Expenses ¥0.0B, yielding Ordinary Income of ¥-0.9B. Extraordinary losses were negligible (loss on disposal of fixed assets ¥0.0B), and income before income taxes was ¥-1.0B. Income taxes amounted to ¥-0.2B (tax benefit), resulting in a final Net Loss of ¥-0.8B. Comprehensive income was also ¥-0.8B, matching Net Income, indicating no temporary valuation differences. In conclusion, this quarter resulted in revenue growth but profit decline.
[Profitability] Operating Margin -3.2% (prior year +9.2%) and Net Margin -2.4% (prior year +6.5%) deteriorated sharply. Gross Margin 72.5% (down 4.3pt from 76.8%) and SG&A Ratio 75.7% (up 8.1pt from 67.6%) show rapid deterioration in operating profitability. ROE -1.0% (prior year +2.1%) declined due to losses, reducing shareholder returns. [Cash Quality] Alongside operating losses, inventories increased to ¥13.8B (YoY +¥3.1B +28.5%) and trade payables decreased to ¥1.9B (YoY -¥1.8B -48.7%), causing notable working capital absorption. Cash and deposits declined to ¥42.5B (¥57.0B prior year, -¥14.5B -25.5%), indicating weak cash conversion. [Investment Efficiency] Total assets were ¥90.2B (¥94.9B prior year, -¥4.7B), and Net Assets ¥77.2B (¥80.5B prior year, -¥3.3B), reflecting a contraction in asset scale due to operating losses and cash outflows. EPS was ¥-0.55 (prior year +1.21) and BPS ¥55.39 (prior year 57.71, -¥2.32), indicating a reduction in net asset value. [Financial Soundness] Equity Ratio remained high at 85.6% (up 0.8pt from 84.8% prior year), and liquidity ratios are strong with Current Ratio 616% (Current Assets ¥76.5B ÷ Current Liabilities ¥12.4B) and Quick Ratio 505%, indicating very robust short-term payment capacity. There is no interest-bearing debt; Debt-to-Equity Ratio 0.17x and Financial Leverage 1.17x reflect a conservative capital structure.
In addition to the operating loss of ¥-1.0B, inventory accumulation (+¥3.1B) and a decrease in trade payables (-¥1.8B) absorbed cash from working capital, likely resulting in negative Operating Cash Flow (OCF). Cash and deposits fell to ¥42.5B, a YoY decrease of ¥-14.5B (-25.5%), with inventory investment and reduction in payables as the main causes of cash outflow. Product inventory ¥13.8B plus raw materials ¥2.3B, totaling ¥16.1B, equals roughly 50% of revenue ¥32.1B, suggesting prolonged inventory turnover. Liquidity remains ample, so short-term funding risk is limited, but improving cash generation via inventory digestion and optimization of payables terms is a key challenge.
Quality of earnings deteriorated as the company moved into an operating loss. The 4.3pt decline in gross margin appears to include temporary factors such as changes in product mix and discounting pressure related to inventory build-up, while the 8.1pt rise in SG&A ratio is likely due to front-loaded spending on advertising and promotions. Non-operating income was modest at ¥0.1B, so there is little divergence between Ordinary Income and Operating Income, and contributions from non-core activities are limited. Extraordinary losses were minor (loss on disposal of fixed assets ¥0.0B), indicating limited impact from one-off items. Comprehensive income of ¥-0.8B equals Net Income of ¥-0.8B, showing no unrealized valuation gains or losses. A tax benefit of ¥-0.2B helped reduce the final loss but does not represent fundamental earnings recovery. Overall, deterioration at the operating level has reduced earnings quality; inventory digestion and improved advertising efficiency are key focus areas going forward.
Full Year / FY guidance was maintained at Revenue ¥159.6B (YoY +42.4%), Operating Income ¥10.6B (YoY +5.9%), Ordinary Income ¥10.8B (YoY +4.2%), Net Income ¥7.3B, EPS ¥5.26, and Dividends ¥1.70. Q1 progress rates show Revenue at 20.1% (¥32.1B ÷ ¥159.6B), slightly below the standard 25% pace; Operating Income and Ordinary Income are in loss so progress rates are not applicable and are substantially behind. The company did not revise guidance and appears to expect significant recovery in H2 driven by inventory digestion and improved promotion efficiency. Achieving the full-year revenue-and-profit growth target requires recovery in gross margin (product mix improvement) and reduction in SG&A ratio (ad efficiency improvement); progress from Q2 onward will be a critical factor for judgment.
Dividend guidance remains at ¥1.70 per annum (presumably ¥0.85 interim and ¥0.85 year-end), implying a Payout Ratio of approximately 32.3% against the full-year EPS forecast of ¥5.26, a sustainable level. Although Q1 was loss-making, if full-year profit targets are met, dividend stability appears preserved. Cash and deposits of ¥42.5B and Net Assets ¥77.2B indicate a solid financial base, and the short-term loss does not currently threaten dividend-paying capacity. There is no disclosure on share buybacks; shareholder returns are focused on dividends. Evaluation of dividend yield and Total Return Ratio requires market price information, but based on the payout level, the policy appears to emphasize a balance with internal reserves.
Front-loading of SG&A and efficiency deterioration risk: SG&A ¥24.3B (YoY +38.4%) substantially outpaced revenue growth of +23.6%, and SG&A Ratio rose to 75.7% (up 8.1pt from 67.6%). If advertising and promotion front-loading is temporary, improvement in margins from Q2 onward is possible; however, if customer acquisition efficiency deteriorates persistently, pressure on Operating Margin could continue.
Inventory stagnation and impairment risk: Inventories ¥13.8B (YoY +28.5%) represent roughly 43% of revenue ¥32.1B, suggesting prolonged inventory turnover. If inventory digestion lags, markdowns or obsolescence could lead to impairment losses and further pressure on gross margin. Given the composition of product inventory ¥13.8B and raw materials ¥2.3B, the buildup in finished goods is pronounced—attention to demand forecasting versus actuals is necessary.
Working capital deterioration and cash outflow risk: Trade payables ¥1.9B (YoY -48.7%) have decreased significantly, reducing supplier credit usage. Inventory increase +¥3.1B and payables decrease -¥1.8B resulted in working capital absorption and cash declined to ¥42.5B (YoY -25.5%). If high inventory levels persist and payable terms remain shortened, cash conversion could worsen and liquidity buffers could shrink.
Profitability & Returns
| 指標 | 自社 | 中央値 (IQR) | Delta |
|---|---|---|---|
| Operating Margin | -3.2% | 8.8% (4.4%–14.3%) | -12.0pt |
| Net Margin | -2.4% | 7.3% (3.3%–10.6%) | -9.7pt |
Profitability is substantially below the industry median, with a negative gap of 12.0pt in Operating Margin and 9.7pt in Net Margin, placing the company in the lower tier within the industry.
Growth & Capital Efficiency
| 指標 | 自社 | 中央値 (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | 23.6% | 6.6% (-0.3%–14.8%) | +17.0pt |
Revenue growth outpaced the industry median by 17.0pt, positioning the company among the faster top-line growers in the industry, but the trade-off with profitability is evident.
※Source: Company aggregation
Revenue grew +23.6%, well above the industry average, but front-loaded SG&A (+38.4%) and a 4.3pt decline in Gross Margin led to an operating loss—this is the primary focal point of the results. The maintained full-year guidance appears premised on margin recovery via inventory digestion and improved advertising efficiency from Q2 onward; normalization of Gross Margin and SG&A Ratio in the next quarter will be key to achieving full-year targets.
Financial soundness remains high with an Equity Ratio of 85.6% and Cash and Deposits of ¥42.5B, but working capital deterioration (Inventory +28.5%, Trade Payables -48.7%) caused cash to fall YoY -25.5%, highlighting the need to improve cash conversion. Elevated inventory levels carry the risk of manifesting demand-supply gaps, leading to discounting pressure or impairment losses. Improvement in inventory turnover and optimization of payables terms in Q2 will be important indicators of recovery in cash generation.
This report is an AI-generated earnings analysis document produced from XBRL financial statement data. It does not constitute a recommendation to invest in any specific securities. Industry benchmarks are reference information compiled by the company based on public financial statements. Investment decisions are your own responsibility; consult a professional advisor as needed before making investment decisions.
---End of Report---